Approx what percentage of your time do you budget for filling out camp forms?

Our multicenter study on the impact of aneuploidy and chromosome 9p loss on tumor microenvironment and immunotherapy efficacy in #NSCLC is out in JTO & JTO CRR 🚨. w/ Xinan Wang, @ArielleElkrief, @BiagioRicciutMD , Adam J. Schoenfeld, Mark Awad rb.gy/inz2z

Whats the correlation between office badge swipes and average publication impact factor?

That magical time when the new GPUs are installed but no dept wide announcements have been made...

Really excited to see our mIF cohort helping explore clinico-genomic landscape of #NSCLC

Great picture!

New #JITC article: Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study jitc.bmj.com/content/11/7/e… @ArielleElkrief João Alessi, MD Xinan Wang Charlie Rudin Mark Awad

Is there a zoom plugin that turns pie charts into bar charts in real-time?

Looking to hire a lab manager/technician for the new lab at Dana Farber. Please apply to join our group focused on engineering new cell therapies, especially for pediatric cancer. Job description is flexible - experience with mice and T cells preferred. careers.dana-farber.org/job/senior-res…

Skyline will look different in a few years, looking forward to good things Dana-Farber

These initiatives are needed to drive up N. Hopefully the regulatory aspect can become more routine.

Exciting update from Dana-Farber! We’ve been using MatchMiner, an open-source pre-screening tool, to match cancer patients with precision medicine trials for over 8 years—and it’s making a big impact! 🎯 linkedin.com/pulse/matchmin…

Super excited to announce that I will be working with Meta through the #llamaverse impact grant to enhance clinical trial participation in cancer. Stay tuned for more updates and details. Truly thrilling news for hashtag Dana-Farber about.fb.com/news/2024/09/l…

1/ 🔬 Excited to share our collaboration from Dana-Farber Dana-Farber Division of Population Sciences Division of Population Sciences & Knowledge Systems Group: MatchMiner-AI! A new open-source approach to match patients with cancer to potential clinical trials. #AIinOncology